Monday, January 18, 2021

LATEST ARTICLES

Amgen’s AVSOLA™ received FDA approval for AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab)for the treatment of Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis,...

Dec. 6, 2019: U.S. FDA has approved Amgen’s  AVSOLA™ (infliximab-axxq) for all approved indications of the reference product, Remicade® (infliximab): for the treatment of...

ViiV Healthcare submits New Drug Application to the US FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults

Dec 05, 2019: ViiV Healthcare have completed submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA)...

FDA authorizes marketing of diagnostic test cobas vivoDx that uses novel technology to detect Methicillin-resistant Staphylococcus aureus (MRSA) bacteria

Dec 05, 2019: Roche Molecular Systems Inc. received U.S. Food and Drug Administration approval for marketing of a new diagnostic test (Cobas...

First investigational drug therapy for liver disease non alcoholic steatohepatitis (NASH) awaiting FDA approval

Dec. 05, 2019: A large Phase III clinical trial designed in collaboration with Virginia Commonwealth University is the first to demonstrate the...

Data fron XOSPATA® in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual Meeting

Dec. 3, 2019: Astellas Pharma Inc. announced the presentation of new data in acute myeloid leukaemia (AML) at the 61st American Society of...

First generics of Gilenya approved by FDA for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients

Dec 05, 2019: The U.S. Food and Drug Administration approved three applications for the first generics of Gilenya (fingolimod) capsules for the...

U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Alecto’s investigational therapeutic AL001, for the treatment of patients with...

Dec. 05, 2019: U.S. Food and Drug Administration (FDA) has granted Fast Track designation for  Alecto’s investigational therapeutic, AL001, for the treatment...

U.S. FDA approved BMS Breakthrough Therapy Designation for ORENCIA® (abatacept) just to help in Preventing Acute Graft-Versus-Host Disease, a Potentially Life-Threatening Complication...

DEC 04, 2019: Bristol-Myers Squibb Company  announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for ORENCIA® (abatacept)...

U.S. Food and Drug Administration (FDA) approved Investigational New Drug (IND) application for Dominant Negative PD-1 “Armored” Next Generation CAR-T Cell Therapy

Dec. 04, 2019: Innovative Cellular Therapeutics (ICT) announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New...

Ardelyx’s kidney disease drug succeeded in regulating elevated blood phosphate levels in patients with chronic kidney disease (CKD)

Dec 04, 2019, Ardelyx lnc said about its experimental drug succeeded in regulating elevated blood phosphate levels in patients with chronic kidney disease (CKD) in a...

United States Food and Drug Administration (USFDA) approved Bortezomib for Injection (IV) 3.5 mg/vial for the treatment of cancers in adult patients

December 04, 2019: Dr Reddy's Laboratories  launched Bortezomib for Injection (IV) 3.5 mg/vial for the treatment of certain types of cancers in adult...

U.S. Food and Drug Administration (FDA) approved Regenerative Medicine Advanced Therapy (RMAT) designation from the for ADP-A2M4 for the treatment of synovial...

Dec. 03, 2019: U.S. Food and Drug Administration (FDA) approved Adaptimmune Therapeutic’s  Regenerative Medicine Advanced Therapy (RMAT) designation for ADP-A2M4 for the treatment...

Other

What Is a Blockbuster Drug?

What Is a Blockbuster Drug? "Blockbuster drugs are those that generate at least $1 billion of revenue per...

Covaxin: Everything that you should know

Covaxin is an investigational vaccine candidate for COVID19. It is in Phase III clinical trial as of today (20-Dec-2020). It is being...

Interview with Kashish Gupta: NIPER 2020, AIR-36

NIPER is a well renowned institute that offers Master's degree after qualifying GPAT (Graduate Pharmacy Aptitude Test) and NIPER entrance test. NIPER...